FDA seeks end to OTC nasal decongestant

The US Food and Drug Administration says a common oral over-the-counter (OTC) nasal decongestant is ineffective, and it’s proposing to remove it as an active ingredient. The agency’s proposed order would affect phenylephrine, which is in DayQuil, Sudafed PE, and a slew of other OTC cold medicines. It comes more than a year after an FDA advisory panel unanimously agreed that phenylephrine doesn’t work when taken orally .